These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12525446)

  • 1. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.
    Oktay K; Buyuk E; Davis O; Yermakova I; Veeck L; Rosenwaks Z
    Hum Reprod; 2003 Jan; 18(1):90-5. PubMed ID: 12525446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF.
    Mak W; Kondapalli LA; Celia G; Gordon J; DiMattina M; Payson M
    Hum Reprod; 2016 Apr; 31(4):789-94. PubMed ID: 26908846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study.
    Courbiere B; Decanter C; Bringer-Deutsch S; Rives N; Mirallié S; Pech JC; De Ziegler D; Carré-Pigeon F; May-Panloup P; Sifer C; Amice V; Schweitzer T; Porcu-Buisson G; Poirot C;
    Hum Reprod; 2013 Sep; 28(9):2381-8. PubMed ID: 23832792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
    Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z
    J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation.
    Oktay K
    J Clin Oncol; 2005 Jun; 23(16):3858-9. PubMed ID: 15911867
    [No Abstract]   [Full Text] [Related]  

  • 7. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
    Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
    Das M; Shehata F; Son WY; Tulandi T; Holzer H
    Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.
    Oktay K; Hourvitz A; Sahin G; Oktem O; Safro B; Cil A; Bang H
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3885-90. PubMed ID: 16882752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification.
    Sánchez-Serrano M; Crespo J; Mirabet V; Cobo AC; Escribá MJ; Simón C; Pellicer A
    Fertil Steril; 2010 Jan; 93(1):268.e11-3. PubMed ID: 19880105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.
    Oktay K; Buyuk E; Rodriguez-Wallberg KA; Sahin G
    Reprod Biomed Online; 2010 May; 20(5):634-8. PubMed ID: 20219430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
    Letourneau J; Juarez-Hernandez F; Wald K; Ribeiro S; Wang A; McCulloch CE; Mok-Lin E; Dolezal M; Chien AJ; Cedars MI; Rosen M
    J Assist Reprod Genet; 2021 Sep; 38(9):2455-2463. PubMed ID: 34312774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
    Creux H; Monnier P; Son WY; Buckett W
    J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience.
    Cardozo ER; Thomson AP; Karmon AE; Dickinson KA; Wright DL; Sabatini ME
    J Assist Reprod Genet; 2015 Apr; 32(4):587-96. PubMed ID: 25595540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer ovarian stimulation reduces embryo number and clinical pregnancy rate in long GnRH agonist cycles.
    Dunne C; Lawrence C; Albert A; Havelock JC
    Minerva Ginecol; 2017 Apr; 69(2):135-140. PubMed ID: 27270672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation.
    Barcroft J; Dayoub N; Thong KJ
    J Assist Reprod Genet; 2013 Nov; 30(11):1407-13. PubMed ID: 23835721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.